<DOC>
	<DOCNO>NCT00696917</DOCNO>
	<brief_summary>This study conduct evaluate lot-to-lot consistency three lot HBV-MPL vaccine compare safety immunogenicity Engerix™-B .</brief_summary>
	<brief_title>Safety Immunogenicity 3 Lots GSK Biologicals ' HBV-MPL Vaccine Engerix™-B Healthy Volunteers ≥ 15y</brief_title>
	<detailed_description>At time conduct study , sponsor GlaxoSmithKline know former name SmithKline Beecham</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female age ≥ 15 year time first vaccination . In Centre 103 ( Germany ) Centre 1 ( Netherlands ) , subject ≥ 18 year enrol . Free obvious health problem establish medical history clinical examination enter study . Written inform consent obtain subject and/or parent guardian subject . If subject female , nonchildbearing potential , childbearing potential , abstinent use adequate contraceptive precaution one month prior enrollment two month last vaccination Use investigational nonregistered drug vaccine study vaccine ( ) study period within 30 day precede first dose study vaccine . Planned administration/ administration vaccine foreseen study protocol period start 30 day dose vaccine end 30 day . Previous vaccination hepatitis B . History nonresponse previous hepatitis B vaccination . Known exposure hepatitis B within past 6 week . History hepatitis B infection . Confirmed human immunodeficiency virus ( HIV ) infection . A family history congenital hereditary immunodeficiency . History allergic disease reaction likely exacerbate component vaccine . Acute disease time enrollment . Hepatomegaly , right upper quadrant abdominal pain tenderness . Administration immunoglobulins and/or blood product within three month precede first dose study vaccine plan administration/ administration study period . Pregnant lactate female</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Adjuvanted Hepatitis B vaccine</keyword>
	<keyword>Recombinant Hepatitis B vaccine</keyword>
</DOC>